EoCene Ltd. (EOCN) stock
EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.46−0.07 (-2.77%)
Close on Nov 17, 2026Market cap $2.46MP/E –Yield –
EoCene total assets
Total assets on the balance sheet at the end of each period.
EoCene's total assets was $18.28M at Jun 30, 2026. For fiscal 2025 it was $18.63M, up 0.7% from the year before. Over ten years it grew -2.6% a year on average. The highest annual figure on record is $90.60M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.63M | +0.7% |
| FY2024 | Dec 31, 2024 | $18.50M | +11.3% |
| FY2023 | Dec 31, 2023 | $16.63M | +0.4% |
| FY2022 | Dec 31, 2022 | $16.56M | -54.8% |
| FY2021 | Dec 31, 2021 | $36.61M | -30.1% |
| FY2020 | Dec 31, 2020 | $52.38M | -32.1% |
| FY2019 | Dec 31, 2019 | $77.14M | -14.9% |
| FY2018 | Dec 31, 2018 | $90.60M | +361.2% |
| FY2017 | Dec 31, 2017 | $19.64M | +19.4% |
| FY2016 | Dec 31, 2016 | $16.45M | -32.2% |
| FY2015 | Dec 31, 2015 | $24.26M | -26.3% |
| FY2014 | Dec 31, 2014 | $32.93M | +19734.3% |
| FY2013 | Dec 31, 2013 | $166.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $18.28M | -1.2% |
| Q4 FY2025 | Dec 31, 2025 | $18.63M | +39.6% |
| Q3 FY2025 | Sep 30, 2025 | $21.58M | +29.8% |
| Q2 FY2025 | Jun 30, 2025 | $22.94M | +72.8% |
| Q4 FY2024 | Dec 31, 2024 | $18.50M | +11.7% |
| Q2 FY2024 | Jun 30, 2024 | $13.34M | -43.4% |
| Q4 FY2023 | Dec 31, 2023 | $16.63M | -54.6% |
| Q2 FY2023 | Jun 30, 2023 | $13.28M | -74.6% |
| Q4 FY2022 | Dec 31, 2022 | $16.56M | -68.4% |
| Q2 FY2022 | Jun 30, 2022 | $23.58M | -63.6% |
| Q4 FY2021 | Dec 31, 2021 | $36.61M | -52.5% |
| Q2 FY2021 | Jun 30, 2021 | $52.33M | -38.5% |
| Q4 FY2020 | Dec 31, 2020 | $52.38M | -42.2% |
| Q2 FY2020 | Jun 30, 2020 | $64.85M | -31.6% |
| Q4 FY2019 | Dec 31, 2019 | $77.14M | +292.7% |
| Q2 FY2019 | Jun 30, 2019 | $85.11M | +748.8% |
| Q4 FY2018 | Dec 31, 2018 | $90.60M | +450.8% |
| Q2 FY2018 | Jun 30, 2018 | $94.85M | +426.9% |
| Q4 FY2017 | Dec 31, 2017 | $19.64M | -19.0% |
| Q2 FY2017 | Jun 30, 2017 | $10.03M | -69.5% |
| Q4 FY2016 | Dec 31, 2016 | $16.45M | +9809.6% |
| Q2 FY2016 | Jun 30, 2016 | $18.00M | – |
| Q4 FY2015 | Dec 31, 2015 | $24.26M | – |
| Q4 FY2014 | Dec 31, 2014 | $32.93M | – |
| Q4 FY2013 | Dec 31, 2013 | $166.00K | – |
See a number that looks wrong?